“…Due to the low sensitivity and specificity of AFB microscopy when compared with culture method ( Karadaǧ et al, 2013 ; Molicotti et al, 2014 ; Pk et al, 2017 ; Bahr et al, 2018 ), molecular methods (as Xpert ® MTB/RIF assay) were introduced to improve the speed and specificity of TB diagnosis mainly in the context of extrapulmonary and FFPE samples, when bacterial load is low, and culture is not even possible. Sensitivities of Xpert ® MTB/RIF and its ultra version reported in fresh non-FFPE clinical samples, so far, are always higher than 60% ( Tortoli et al, 2012 ; Sauzullo et al, 2016 ; Lee et al, 2017 ; Bahr et al, 2018 ; Dorman et al, 2018 ; Sarfaraz et al, 2018 ; Sulis et al, 2018 ; Aydemir et al, 2019 ; Kohli et al, 2021 ) and can reach more than 90% only in some body districts ( Mazzola et al, 2016 ). The few data available regarding the Xpert assay performances in FFPE samples are based on a few clinical biopsies and reported a wide range of sensitivities, which were not even concordant (from 97.6% in the case of the Ultra version to 53.2% in the case of the first MTB/RIF assay) ( Seo et al, 2014 ; Du et al, 2019 ; Njau et al, 2019 ; Budvytiene and Banaei, 2020 ; Huang et al, 2020 ).…”